Bioreliance Ltd.
FDA inspection history in Tampa, Florida, 2009
- 1
- Form 483
Every document, by year
- Form 483
2009: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2009One Form 483, at Tampa, Florida.
Cited most
Across all Bioreliance observations on file
- 21 CFR 1271.160Establishment and maintenance of a quality program1
- 21 CFR 1271.190Facilities1
- 21 CFR 1271.47What procedures must I establish and maintain?1
The complete Bioreliance file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Tampa, Florida
One Form 483 · 2009 · 4 observations
Latest: Form 483, Dec 12, 2009 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2009-12-12 | 483 Form 483 | Tampa, Florida | 4 | $99 |
Investigators on these documents
FEI number 1122041 · most recent document Dec 12, 2009
About Bioreliance Ltd.
How many FDA Form 483s has Bioreliance Ltd. received?
FDA Intel has 1 Form 483 on file for Bioreliance Ltd.; the most recent is dated Dec 12, 2009.
When was Bioreliance Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Bioreliance Ltd. is a Form 483 dated Dec 12, 2009, for the site in Tampa, Florida.
What did FDA cite at Bioreliance Ltd.?
The regulations cited most in the observations on file for Bioreliance Ltd. are 21 CFR 1271.160 (Establishment and maintenance of a quality program), 1 time; 21 CFR 1271.190 (Facilities), 1 time; 21 CFR 1271.47 (What procedures must I establish and maintain?), 1 time.